An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for more than two years, raising questions about whether CAR T-cell therapy could offer a path toward a cure.
|Articles|June 20, 2011
- Summer 2011
- Volume 10
- Issue 2
The Health Care Law: Rhetoric and Reality
Author(s)Elizabeth Whittington
The Healthcareandyou.org website is dedicated to helping people make sense of the new healthcare law.
Advertisement
With the often confusing political rhetoric about the new health care law, it’s nice to know there’s a website dedicated to helping people make sense of it.
Healthcareandyou.org is sponsored by nine well-known and reputable organizations, including the AARP, the American Medical Association and the American Cancer Society Cancer Action Network. The site breaks down the law’s provisions by state and age, and also provides a timeline for how the new law will continue to be phased into effect.
The site includes updates and recent news items, as well as a glossary that explains lingo such as “doughnut hole” and “exchanges.” It also features a video that outlines some of what the new law already covers, including provisions that allow young adults to stay on their parents’ insurance until age 26 and that children can no longer be denied coverage for a pre-existing condition.
The Patient Protection and Affordable Care Act was signed into law in March 2010 and will be phased in through 2014. You can read more about it in “Financial Aid” from our archives.
Articles in this issue
over 15 years ago
Blog: Standing up to melanomaover 15 years ago
From Our Archives: Advance Directiveover 15 years ago
From Our Archives: Art & Healingover 15 years ago
Teenage Tan Bans Spreading Across Statesover 15 years ago
Prostate Cancer Prevention Drugs Get a “No” Voteover 15 years ago
Nonmelanoma Skin Cancerover 15 years ago
From Our Archives: Skin Cancerover 15 years ago
Risky Infectionsover 15 years ago
Scarred, Scared, SacredAdvertisement
Related to this article
The National Comprehensive Cancer Network released its first patient guideline written for caregivers on Oct. 27, 2026. The free guide covers emotional support, money, legal questions, medical tasks and caregivers' own well-being.
Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
New research found that nearly 1 in 5 second-level appeals for denied cancer medications under Medicare Part D were successful, raising questions about how insurers make coverage decisions and what patients can do when their treatment is denied.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
A national survey study of about 200,000 adults, published in Supportive Care in Cancer, found that people caring for someone with cancer had 89% higher odds of frequent mental distress than people who were not caregivers.
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ESMO 2026 That Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
Life After a Prostate Cancer Diagnosis: Why It’s a Pivot, Not an Ending
4
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
5